Blood processor
Latest Bristol-Myers Squibb Company Patents:
- Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
- Method of purity determination by capillary electrophoresis
- Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
- ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS
- Supramolecular filamentous assemblies for protein purification
Description
FIG. 1 is a front view of the blood processor of the present invention;
FIG. 2 is a side view of the blood processor of the present invention;
FIG. 3 is a top view of the blood processor of the present invention;
FIG. 4 is a front perspective view of the blood processor of the present invention;
FIG. 5 is a rear perspective view of the blood processor of the present invention;
FIG. 6 is a bottom view of the blood processor of the present invention; and,
FIG. 7 is a rear view of the blood processor of the present invention.
Referenced Cited
Patent History
Patent number: D396289
Type: Grant
Filed: Apr 28, 1997
Date of Patent: Jul 21, 1998
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Steve McGugan (Copenhagen)
Primary Examiner: Stella Reid
Attorneys: Theodore R. Furman, Jr., Stuart E. Krieger, John M. Kilcoyne
Application Number: 0/69,559
Type: Grant
Filed: Apr 28, 1997
Date of Patent: Jul 21, 1998
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Steve McGugan (Copenhagen)
Primary Examiner: Stella Reid
Attorneys: Theodore R. Furman, Jr., Stuart E. Krieger, John M. Kilcoyne
Application Number: 0/69,559
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)
International Classification: 2401;
International Classification: 2401;